Skip to main content
SpringerLink
Log in

Rapid emergence of daptomycin resistance in clinical isolates of Corynebacterium striatum… a cautionary tale

  • Article
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

Abstract

The objective of this study was to investigate the observation of daptomycin resistance in Corynebacterium striatum, both in vivo and in vitro. We describe a case of C. striatum bacteremia in a patient with a left ventricular assist device (LVAD); the initial isolate recovered was daptomycin susceptible with a minimum inhibitory concentration (MIC) of 0.125 μg/ml. Two months later, and after daptomycin therapy, the individual became bacteremic with an isolate of C. striatum with a daptomycin MIC of >256 μg/ml. To study the prevalence of daptomycin resistance in C. striatum, clinical isolates of C. striatum were grown in broth culture containing daptomycin to investigate the emergence of resistance to this antimicrobial. Molecular typing was used to evaluate serial isolates from the index patient and the clinical isolates of C. striatum we assayed. In vitro analysis of isolates from the index patient and 7 of 11 additional C. striatum isolates exhibited the emergence of high-level daptomycin resistance, despite initially demonstrating low MICs to this antimicrobial agent. This phenotype was persistent even after serial subculture in the absence of daptomycin. Together, these data demonstrate that caution should be taken when using daptomycin to treat high-inoculum infections and/or infections of indwelling medical devices with C. striatum. To our knowledge, this is the first report characterizing the emergence of daptomycin resistance in C. striatum.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Gould IM, Miró JM, Rybak MJ (2013) Daptomycin: the role of high-dose and combination therapy for Gram-positive infections. Int J Antimicrob Agents 42(3):202–210. doi:10.1016/j.ijantimicag.2013.05.005

    Article  CAS  PubMed  Google Scholar 

  2. Humphries RM, Pollett S, Sakoulas G (2013) A current perspective on daptomycin for the clinical microbiologist. Clin Microbiol Rev 26(4):759–780. doi:10.1128/CMR.00030-13

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Rybak JM, Barber KE, Rybak MJ (2013) Current and prospective treatments for multidrug-resistant gram-positive infections. Expert Opin Pharmacother 14(14):1919–1932. doi:10.1517/14656566.2013.820276

    Article  CAS  PubMed  Google Scholar 

  4. Corona Pérez-Cardona PS, Barro Ojeda V, Rodriguez Pardo D, Pigrau Serrallach C, Guerra Farfán E, Amat Mateu C, Flores Sanchez X (2012) Clinical experience with daptomycin for the treatment of patients with knee and hip periprosthetic joint infections. J Antimicrob Chemother 67(7):1749–1754. doi:10.1093/jac/dks119

    Article  PubMed  Google Scholar 

  5. Durante-Mangoni E, Casillo R, Bernardo M, Caianiello C, Mattucci I, Pinto D, Agrusta F, Caprioli R, Albisinni R, Ragone E, Utili R (2012) High-dose daptomycin for cardiac implantable electronic device-related infective endocarditis. Clin Infect Dis 54(3):347–354. doi:10.1093/cid/cir805

    Article  CAS  PubMed  Google Scholar 

  6. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) (2014) University of Alabama at Birmingham. Accessed 3 Feb 2014

  7. Lee PP, Ferguson DA Jr, Sarubbi FA (2005) Corynebacterium striatum: an underappreciated community and nosocomial pathogen. J Infect 50(4):338–343. doi:10.1016/j.jinf.2004.05.005

    Article  PubMed  Google Scholar 

  8. Funke G, von Graevenitz A, Clarridge JE 3rd, Bernard KA (1997) Clinical microbiology of coryneform bacteria. Clin Microbiol Rev 10(1):125–159

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Goldstein EJ, Citron DM, Merriam CV, Warren Y, Tyrrell K, Fernandez HT (2003) In vitro activities of dalbavancin and nine comparator agents against anaerobic gram-positive species and corynebacteria. Antimicrob Agents Chemother 47(6):1968–1971

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Goldstein EJ, Citron DM, Merriam CV, Warren YA, Tyrrell KL, Fernandez HT (2003) In vitro activities of daptomycin, vancomycin, quinupristin- dalfopristin, linezolid, and five other antimicrobials against 307 gram-positive anaerobic and 31 Corynebacterium clinical isolates. Antimicrob Agents Chemother 47(1):337–341

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Ernst CM, Staubitz P, Mishra NN, Yang SJ, Hornig G, Kalbacher H, Bayer AS, Kraus D, Peschel A (2009) The bacterial defensin resistance protein MprF consists of separable domains for lipid lysinylation and antimicrobial peptide repulsion. PLoS Pathog 5(11):e1000660. doi:10.1371/journal.ppat.1000660

    Article  PubMed  PubMed Central  Google Scholar 

  12. Yang SJ, Kreiswirth BN, Sakoulas G, Yeaman MR, Xiong YQ, Sawa A, Bayer AS (2009) Enhanced expression of dltABCD is associated with the development of daptomycin nonsusceptibility in a clinical endocarditis isolate of Staphylococcus aureus. J Infect Dis 200(12):1916–1920. doi:10.1086/648473

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Mwangi MM, Wu SW, Zhou Y, Sieradzki K, de Lencastre H, Richardson P, Bruce D, Rubin E, Myers E, Siggia ED, Tomasz A (2007) Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing. Proc Natl Acad Sci U S A 104(22):9451–9456. doi:10.1073/pnas.0609839104

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Kaatz GW, Lundstrom TS, Seo SM (2006) Mechanisms of daptomycin resistance in Staphylococcus aureus. Int J Antimicrob Agents 28(4):280–287. doi:10.1016/j.ijantimicag.2006.05.030

    Article  CAS  PubMed  Google Scholar 

  15. Friedman L, Alder JD, Silverman JA (2006) Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus. Antimicrob Agents Chemother 50(6):2137–2145. doi:10.1128/AAC.00039-06

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Yang SJ, Xiong YQ, Dunman PM, Schrenzel J, François P, Peschel A, Bayer AS (2009) Regulation of mprF in daptomycin-nonsusceptible Staphylococcus aureus strains. Antimicrob Agents Chemother 53(6):2636–2637. doi:10.1128/AAC.01415-08

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Bayer AS, Schneider T, Sahl HG (2013) Mechanisms of daptomycin resistance in Staphylococcus aureus: role of the cell membrane and cell wall. Ann N Y Acad Sci 1277:139–158. doi:10.1111/j.1749-6632.2012.06819.x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Arias CA, Panesso D, McGrath DM, Qin X, Mojica MF, Miller C, Diaz L, Tran TT, Rincon S, Barbu EM, Reyes J, Roh JH, Lobos E, Sodergren E, Pasqualini R, Arap W, Quinn JP, Shamoo Y, Murray BE, Weinstock GM (2011) Genetic basis for in vivo daptomycin resistance in enterococci. N Engl J Med 365(10):892–900. doi:10.1056/NEJMoa1011138

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Munita JM, Tran TT, Diaz L, Panesso D, Reyes J, Murray BE, Arias CA (2013) A liaF codon deletion abolishes daptomycin bactericidal activity against vancomycin-resistant Enterococcus faecalis. Antimicrob Agents Chemother 57(6):2831–2833. doi:10.1128/AAC.00021-13

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Palmer KL, Daniel A, Hardy C, Silverman J, Gilmore MS (2011) Genetic basis for daptomycin resistance in enterococci. Antimicrob Agents Chemother 55(7):3345–3356. doi:10.1128/AAC.00207-11

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Munita JM, Panesso D, Diaz L, Tran TT, Reyes J, Wanger A, Murray BE, Arias CA (2012) Correlation between mutations in liaFSR of Enterococcus faecium and MIC of daptomycin: revisiting daptomycin breakpoints. Antimicrob Agents Chemother 56(8):4354–4359. doi:10.1128/AAC.00509-12

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Schoen C, Unzicker C, Stuhler G, Elias J, Einsele H, Grigoleit GU, Abele-Horn M, Mielke S (2009) Life-threatening infection caused by daptomycin-resistant Corynebacterium jeikeium in a neutropenic patient. J Clin Microbiol 47(7):2328–2331. doi:10.1128/JCM.00457-09

    Article  PubMed  PubMed Central  Google Scholar 

  23. Tran TT, Jaijakul S, Lewis CT, Diaz L, Panesso D, Kaplan HB, Murray BE, Wanger A, Arias CA (2012) Native valve endocarditis caused by Corynebacterium striatum with heterogeneous high-level daptomycin resistance: collateral damage from daptomycin therapy? Antimicrob Agents Chemother 56(6):3461–3464. doi:10.1128/AAC.00046-12

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. McElvania Tekippe E, Shuey S, Winkler DW, Butler MA, Burnham CA (2013) Optimizing identification of clinically relevant Gram-positive organisms by use of the Bruker Biotyper matrix-assisted laser desorption ionization-time of flight mass spectrometry system. J Clin Microbiol 51(5):1421–1427. doi:10.1128/JCM.02680-12

    Article  PubMed  PubMed Central  Google Scholar 

  25. Fritz SA, Hogan PG, Camins BC, Ainsworth AJ, Patrick C, Martin MS, Krauss MJ, Rodriguez M, Burnham CA (2013) Mupirocin and chlorhexidine resistance in Staphylococcus aureus in patients with community-onset skin and soft tissue infections. Antimicrob Agents Chemother 57(1):559–568. doi:10.1128/AAC.01633-12

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. El Feghaly RE, Stamm JE, Fritz SA, Burnham CA (2012) Presence of the bla(Z) beta-lactamase gene in isolates of Staphylococcus aureus that appear penicillin susceptible by conventional phenotypic methods. Diagn Microbiol Infect Dis 74(4):388–393. doi:10.1016/j.diagmicrobio.2012.07.013

    Article  PubMed  Google Scholar 

  27. Clinical and Laboratory Standards Institute (CLSI) (2013) Performance standards for antimicrobial susceptibility testing; Twenty-third informational supplement. CLSI document M100-S23. CLSI, Wayne, PA

  28. Ghide S, Jiang Y, Hachem R, Chaftari AM, Raad I (2010) Catheter-related Corynebacterium bacteremia: should the catheter be removed and vancomycin administered? Eur J Clin Microbiol Infect Dis 29(2):153–156. doi:10.1007/s10096-009-0827-0

    Article  CAS  PubMed  Google Scholar 

  29. Fernández Guerrero ML, Molins A, Rey M, Romero J, Gadea I (2012) Multidrug-resistant Corynebacterium striatum endocarditis successfully treated with daptomycin. Int J Antimicrob Agents 40(4):373–374. doi:10.1016/j.ijantimicag.2012.06.001

    Article  PubMed  Google Scholar 

  30. Fernández Guerrero ML, Robles I, Nogales Mdel C, Nuevo D (2013) Corynebacterium striatum: an emerging nosocomial drug-resistant endocardial pathogen. J Heart Valve Dis 22(3):428–430

    PubMed  Google Scholar 

  31. Sader HS, Flamm RK, Farrell DJ, Jones RN (2013) Daptomycin activity against uncommonly isolated streptococcal and other gram-positive species groups. Antimicrob Agents Chemother 57(12):6378–6380. doi:10.1128/AAC.01906-13

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Fernandez-Roblas R, Adames H, Martín-de-Hijas NZ, Almeida DG, Gadea I, Esteban J (2009) In vitro activity of tigecycline and 10 other antimicrobials against clinical isolates of the genus Corynebacterium. Int J Antimicrob Agents 33(5):453–455. doi:10.1016/j.ijantimicag.2008.11.001

    Article  CAS  PubMed  Google Scholar 

  33. van Hal SJ, Paterson DL, Gosbell IB (2011) Emergence of daptomycin resistance following vancomycin-unresponsive Staphylococcus aureus bacteraemia in a daptomycin-naïve patient—a review of the literature. Eur J Clin Microbiol Infect Dis 30(5):603–610. doi:10.1007/s10096-010-1128-3

    Article  PubMed  Google Scholar 

  34. Montero CI, Stock F, Murray PR (2008) Mechanisms of resistance to daptomycin in Enterococcus faecium. Antimicrob Agents Chemother 52(3):1167–1170. doi:10.1128/AAC.00774-07

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Bryant KA, Roberts AL, Rupp ME, Anderson JR, Lyden ER, Fey PD, Van Schooneveld TC (2013) Susceptibility of enterococci to daptomycin is dependent upon testing methodology. Diagn Microbiol Infect Dis 76(4):497–501. doi:10.1016/j.diagmicrobio.2013.04.019

    Article  CAS  PubMed  Google Scholar 

  36. Palavecino EL, Burnell JM (2013) False daptomycin-nonsusceptible MIC results by Microscan panel PC 29 relative to Etest results for Staphylococcus aureus and enterococci. J Clin Microbiol 51(1):281–283. doi:10.1128/JCM.01721-12

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Nakashima H, Takahashi H, Kameko M, Saito H (2012) Daptomycin Etest MICs for methicillin-resistant Staphylococcus aureus vary among different media. J Infect Chemother 18(6):970–972. doi:10.1007/s10156-012-0424-5

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We would like to thank the Barnes-Jewish Clinical Microbiology Laboratory and Meghan Wallace for their assistance with this project. B.S.T. is supported by the Washington University Institute of Clinical and Translational Sciences grant UL1 TR000448 from the National Center for Advancing Translational Sciences.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Pathology & Immunology, Washington University School of Medicine, 660 South Euclid Avenue, Campus Box 8118, St. Louis, MO, 63110, USA

    E. McElvania TeKippe & C.-A. D. Burnham

  2. Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, 63110, USA

    B. S. Thomas, G. A. Ewald & S. J. Lawrence

  3. Division of Infectious Diseases, Washington University School of Medicine, St. Louis, MO, 63110, USA

    B. S. Thomas & S. J. Lawrence

  4. Division of Cardiology, Washington University School of Medicine, St. Louis, MO, 63110, USA

    G. A. Ewald

Authors
  1. E. McElvania TeKippe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. S. Thomas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. A. Ewald
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. J. Lawrence
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C.-A. D. Burnham
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C.-A. D. Burnham.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

McElvania TeKippe, E., Thomas, B.S., Ewald, G.A. et al. Rapid emergence of daptomycin resistance in clinical isolates of Corynebacterium striatum… a cautionary tale. Eur J Clin Microbiol Infect Dis 33, 2199–2205 (2014). https://doi.org/10.1007/s10096-014-2188-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-014-2188-6

Keywords

Search

Navigation